Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Publication of MY105242ApublicationCriticalpatent/MY105242A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
CERTAIN 1-HETEROARYL-3-ACYL-2-OXINDOLES WHEREIN THE ACYL-SUBSTITUENT IS THENOYL, FUROYL, BENZOYL OR SUBSTITUTED BENZOYL, ARE INHIBITORS OF CYCLOXYGENASE AND LIPOXYGENASE ENZYMES AND ARE USEFUL AS ANTI- INFLAMMATORY AGENTS IN MAMMALS.
APPLICATION OF BACTERIA, ASSOCIATED WITH ARGINIDESYMINASE, FOR THE INDUCTION OF APOPTOSIS AND / OR REDUCTION OF INFLAMMATORY REACTION AND PHARMACEUTICAL OR DIETARY COMPOSITIONS CONTAINING SUCH BACTERIA